期刊文献+

肠促胰岛素系统——治疗2型糖尿病的新动向

Incretin system——a new trend for treatment of type 2 diabetes
下载PDF
导出
摘要 随着2型糖尿病发病率的逐年增加,临床出现了多种治疗2型糖尿病的新药,其中肠促胰岛素系统相关药物备受关注。本文简要介绍肠促胰岛素系统相关药物。 In recent years, many kinds of new drugs for the treatment of type 2 diabetes have been developed followed the increasing morbidity of type 2 diabetes, among which incretin system related drugs obtained great attention. This article reviewed the development of incretin system related drugs.
出处 《世界临床药物》 CAS 2009年第5期304-305,311,共3页 World Clinical Drug
关键词 肠促胰岛素 胰高血糖素 糖尿病 非胰岛素依赖型 incretin glucagon peptide diabetes mellitus non-insulin-dependent
  • 相关文献

参考文献8

  • 1Goldberg RB,Holman R,Drucker DJ.Clinical decisions.Management of type2diabetes[].The New England Journal of Medicine.2008
  • 2Amori RE,Lau J,Pittas AG,et al.Efficacy and safety of incretin therapy in type2diabetes:systemic review and meta-analysis[].The Journal of The American Medical Association.2007
  • 3Pham DQ,Nogid A,Plakogiannis R.Sitagliptin:a novel agent for the management of type2diabetes mellitus[].American Journal of Health System Pharmacy.2008
  • 4McMahon GT,Arky RA.Inhaled insulin for diabetes mellitus[].The New England Journal of Medicine.2007
  • 5Elrick,H,Stimmler,L,Hlad,CJ,Arai,Y.Plasma insulin responses to oral and intravenous glucose administration[].The Journal of Clinical Endocrinology.1964
  • 6Dupre,J,Ross,SA,Watson,D,Brown,JC.Stimulation of insulin secretion by gastric inhibitory polypeptide in man[].The Journal of Clinical Endocrinology.1973
  • 7Drucker,D.J.,Nauck,M.A.The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes[].The Lancet.2006
  • 8Orskov,C.,Wettergren,A.,Holst,J. J.Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable[].Diabetes.1993

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部